10 Recruiting Trials

Clinical Trials
for Asthma in Georgia

10 clinical trials for Asthma are currently recruiting participants at study sites in Georgia. Study-related care is provided at no cost.

10
Recruiting trials
13
Study sites
9
Cities
10
Industry-sponsored
3
Phase 2
5
Phase 3

Asthma clinical trials in Georgia: what to expect

Most recruiting asthma trials are for moderate-to-severe asthma that stays uncontrolled on an inhaled steroid. They test biologic injections aimed at the type of inflammation driving your asthma, new inhaler combinations, and longer-acting versions of existing drugs. Others study asthma in children, exercise and self-management programs, and ways to reduce flare-ups that lead to urgent care visits.

In Georgia, recruiting asthma studies are concentrated in Columbus, Atlanta, East Point and Savannah, with sites in 5 other cities. 10 of the 10 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who asthma trials usually look for

Trials ask for a confirmed diagnosis, a daily maintenance inhaler at a stated dose, and usually one or two flare-ups in the past year that needed oral steroids. Breathing tests at screening must fall in a range, and biologic trials pick participants by a blood eosinophil count or allergy markers measured at the site. Most adult trials exclude current smokers and people with COPD or another lung disease. Separate studies enroll children aged 6 to 11 and teenagers.

What taking part involves

Screening includes spirometry and blood work, then a run-in of a few weeks while you record symptoms and inhaler use in a diary or app. Biologic trials give an injection every two to eight weeks for six to twelve months, with breathing tests at each visit; many are placebo controlled, with your regular inhalers continued throughout and rescue inhaler always allowed. Flare-ups during the study are treated as usual. Study treatment and tests are free and visits are usually paid.

Questions worth asking the study team

Whether your current inhalers stay the same or are switched to a study inhaler; how often breathing tests are needed; the chance of placebo and whether an extension follows; and what to do during a flare-up while enrolled.

Showing 10 of 10 recruiting Asthma trials in Georgia

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
PHASE3 Montgomery, Alabama +4 sites NCT06023589
This trial is looking for children aged 5 to under 12 with severe asthma. Participants will receive either the treatment or a placebo for their asthma management.
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
PHASE3 Anchorage, Alaska +4 sites NCT06307665
This trial is looking for adolescents aged 12 to 17 with asthma. Participants will compare two treatments for asthma that are used when needed to see which is more effective and safe.
Recruiting
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
PHASE3 Birmingham, Alabama +4 sites NCT05757102
This trial is looking for teenagers with asthma who need regular medication to manage their symptoms. Participants will receive a new treatment for 24 weeks to see how well it helps their asthma.
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
PHASE3 Phoenix, Arizona +4 sites NCT06664619
This trial is looking for people aged 12 and older who have been diagnosed with asthma for at least six months and currently use a quick-relief inhaler. However, it cannot include anyone who has had serious asthma attacks, recent respiratory infections, or other serious lung problems. If you're a current smoker or have recently smoked, you wouldn't be able to participate either.
Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
PHASE2 Mobile, Alabama +4 sites NCT06977581
This trial is looking for adults with moderate-to-severe asthma that is not well controlled. Participants will receive shots of either the study medicine PF-07275315 or a placebo for 12 weeks and attend clinic visits over about 7.5 months.
Recruiting
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
PHASE2 Birmingham, Alabama +4 sites NCT07301255
This trial is looking for adults with moderate to severe asthma. Participants will take either the study drug ENV-294 or a placebo once a day for 12 weeks while continuing their asthma treatments.
Recruiting
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
N/A Bessemer, Alabama +4 sites NCT07556159
This trial is looking for people with asthma to understand their condition better. Participants will share details about their asthma severity, treatments, and health-related quality of life.
Recruiting
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
N/A Columbus, Georgia +4 sites NCT07228026
This trial is looking for people with asthma to help measure breathing changes using a device called fenoTRACK. Participants will either have uncontrolled asthma or controlled asthma and will be asked to take part in procedures over a few visits.
Recruiting
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
PHASE3 Northridge, California +4 sites NCT07276724
This trial is looking for adults and teenagers with severe asthma that isn't controlled well by their current treatments. Participants will receive either the study drug GB-0895 or a placebo every six months for a year, with regular check-ins.
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
PHASE2 Lancaster, California +4 sites NCT07323654
This trial is looking for adults aged 18 to 75 who have moderate to severe eosinophilic asthma that is not well controlled. Participants will take a medication called KT-621 to see how well it works and monitor any side effects.
Recruiting

Where the Asthma studies are in Georgia

  • Research Site, Atlanta2 trials
  • AllerVie Clinical Research, Columbus1 trial
  • Cpcc-Research Llc, East Point1 trial
  • Enveda Investigative Site, Albany1 trial
  • GSK Investigational Site, Savannah1 trial
  • Kymera Investigative Site, East Point1 trial

Counts are recruiting studies listing at least one site in Georgia, from ClinicalTrials.gov, refreshed every two days.

Asthma clinical trials in Georgia: common questions

How many Asthma clinical trials are recruiting in Georgia?
TrialFinder currently lists 10 recruiting Asthma clinical trials with study sites in Georgia. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Asthma clinical trials located in Georgia?
Study sites for the Asthma trials listed on this page include Columbus. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Asthma clinical trial in Georgia?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Asthma trials in Georgia also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Asthma clinical trial in Georgia?
Each study sets its own criteria based on age, Asthma diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Do I need to stop my inhaler to join an asthma trial?
No. Trials add the study treatment to your maintenance inhaler, or replace it with a study-supplied version, and a rescue inhaler is always permitted. Any change is made by the study doctor.
What is an eosinophil count and why do trials ask about it?
It is a type of white blood cell measured in a routine blood test. Many biologic asthma drugs target the inflammation it signals, so trials set a minimum or maximum count. The site measures it at screening.
Are there asthma trials for children?
Yes. Biologics and inhalers approved for adults are studied in children aged 6 to 11 and in teenagers, with a parent consenting and attending visits. The listing states the age range.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Asthma trials near you in Georgia.

Get Matched — Free
No insurance required

Asthma trials evaluate biologic therapies, inhaler formulations, allergen immunotherapy, and environmental interventions for moderate-to-severe asthma and COPD overlap.

All Asthma trials →